Lacrimal Duct Stent Tube Market to Witness a Healthy Growth by 2029

Introduction of upgraded and highly precise lacrimal duct stent tube for canalicular stenosis or obstruction and congenital nasolacrimal duct obstruction remains a key booster to the growth of lacrimal duct stent tube market. The global market for lacrimal duct stent tube is projected for a promising 6% CAGR during 2019 – 2029, as suggested by a new Future Market Insights (FMI) report.

There has been higher preference for bicanalicular lacrimal duct stent tube over its monocanalicular counterpart, attributing to the former’s high success rate, suitability for stenting in older patients, and better clinical outcomes. Moreover, increasing prevalence of retina-related conditions, primarily imperforation of nasolacrimal duct, epiphora both in infants and adults, and conditions necessitating dacryocystorhinostomy are other factors responsible for propelling revenue growth of the lacrimal duct stent tube market.

Get Sample of the Report : https://www.futuremarketinsights.com/reports/sample/rep-gb-9649

Consistent efforts towards diagnosis and management of lacrimal duct obstruction with enhanced success rate, minimally invasive lacrimal surgery, and better clinical outcomes, and increasing product awareness among ophthalmologist are factors augmenting growth prospects for the lacrimal duct stent tube market.

Key Takeaways – Lacrimal Duct Stent Tube Market Study

  • Bicanalicular lacrimal duct stent tube is expected to contribute three fourth of revenue share in the lacrimal duct stent tube market owing to its high success rate in stent placement.
  • Hospitals captured maximum share of the lacrimal duct stent tube market owing to highest patient footfall followed by ophthalmic clinics.
  • Attributed to growing patient pool for retinal diseases, especially due to premature births, contributed to the dominance of North America in the lacrimal duct stent tube market.
  • Increasing awareness for availability of the treatment for nasolacrimal duct stent obstruction among caregivers of prematurely born babies and increasing number of skilled professionals are expected to drive growth of the lacrimal duct stent tube market in East Asia.
lacrimal duct stent tube market share by region

Ask For Regional Data : https://www.futuremarketinsights.com/ask-regional/rep-gb-9649

Manufacturers Emphasizing Advanced Product Development

Numerous organizations are focusing on new product development for lacrimal duct stent tube. In June 2019, FCI Ophthalmic offered a complete line of BIKA stents namely, BIKA, BIKA for DCR, and Infant BIKA covering a range of sizes that will benefit most of the congenital nasolacrimal duct obstruction (CNLDO) and dacryocystorhinostomy (DCR) cases.

Leave a comment

Your email address will not be published.